- Global Pharma News & Resources

Neurosurgical Products Medical Devices Pipeline Assessment, 2020 Report -

DUBLIN--(BUSINESS WIRE)--The "Neurosurgical Products - Medical Devices Pipeline Assessment, 2020" report has been added to's offering.

"Neurosurgical Products - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Neurosurgical Products pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Neurosurgical Products are specialized surgical devices used for performing neurosurgical procedures. Dura Substitutes, Neuroendoscopes and Neurosurgical Drills are tracked under this category.


  • Extensive coverage of the Neurosurgical Products under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Neurosurgical Products and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to Buy

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Neurosurgical Products under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Key Topics Covered:

1 Table of Contents

1.1 List of Tables

1.2 List of Figures

2 Introduction

2.1 Neurosurgical Products Overview

3 Products under Development

3.1 Neurosurgical Products - Pipeline Products by Stage of Development

3.2 Neurosurgical Products - Pipeline Products by Segment

3.3 Neurosurgical Products - Pipeline Products by Territory

3.4 Neurosurgical Products - Pipeline Products by Regulatory Path

3.5 Neurosurgical Products - Pipeline Products by Estimated Approval Date

3.6 Neurosurgical Products - Ongoing Clinical Trials

4 Neurosurgical Products - Pipeline Products under Development by Companies

4.1 Neurosurgical Products Companies - Pipeline Products by Stage of Development

4.2 Neurosurgical Products - Pipeline Products by Stage of Development

5 Neurosurgical Products Companies and Product Overview

5.1 Alcyone Lifesciences Inc Company Overview

5.1.1 Alcyone Lifesciences Inc Pipeline Products & Ongoing Clinical Trials Overview

5.2 Aleva Neurotherapeutics SA Company Overview

5.3 Augusta University Company Overview

5.4 Axion BioSystems Inc Company Overview

5.5 C2C Development, LLC Company Overview

5.6 Carnegie Mellon University Company Overview

5.7 Carthera SAS Company Overview

5.8 Cartosense Pvt Ltd Company Overview

5.9 Cizeta Surgical Company Overview

5.10 Cornell University Company Overview

5.11 Elite Surgical Supplies (Pty) Ltd Company Overview

5.12 InSightec Ltd Company Overview

5.13 Integra LifeSciences Holdings Corp Company Overview

5.14 International HIFU Company Overview

5.15 InVivo Therapeutics Corp Company Overview

5.16 JetGuide Ltd Company Overview

5.17 Johns Hopkins University Company Overview

5.18 KARL STORZ SE & Co KG Company Overview

5.19 Kerecis ehf Company Overview

5.20 Kuros Biosciences AG Company Overview

5.21 LeMaitre Vascular Inc Company Overview

5.22 Massachusetts Institute of Technology Company Overview

5.23 Mayo Clinic Company Overview

5.24 Medtronic Navigation Inc Company Overview

5.25 MRC Systems GmbH Company Overview

5.26 Nanonerve Inc. Company Overview

5.27 Neuraptive Therapeutics Inc Company Overview

5.28 Nurami Medical Ltd Company Overview

5.29 Orthocell Ltd Company Overview

5.30 PediaWorks Inc Company Overview

5.31 Replication Medical Inc Company Overview

5.32 Resultados y Calidad del Sistema Sanitario Publico de Andalucia Company Overview

5.33 Skull Base Institute Company Overview

5.34 Sree Chitra Tirunal Institute for Medical Sciences & Technology Company Overview

5.35 Surgify Medical Oy Company Overview

5.36 The Swedish Neuroscience Institute Company Overview

5.37 University of Colorado Company Overview

5.38 University of Maryland Baltimore Company Overview

5.39 University of South Florida Company Overview

5.40 University of Texas Medical Branch at Galveston Company Overview

5.41 University of Utah Company Overview

5.42 Vanderbilt University Company Overview

5.43 Xylos Corporation Company Overview

6 Neurosurgical Products- Recent Developments

6.1 Aug 21, 2020: OssDsign reports successful outcome at 6-month follow-up of clinical study on sinus augmentation

6.2 Aug 13, 2020: Renishaw: Preliminary announcement of unaudited results for the year ended 30 June 2020

6.3 Mar 02, 2020: Stryker announces new Investor Relations leader

6.4 Feb 28, 2020: Leica Microsystems announces new market representation for Mid-Atlantic medical market

6.5 Feb 26, 2020: Mayo Clinic reports 'remarkable growth' in 2019

6.6 Feb 25, 2020: Stryker announces nomination of new Director, Lisa Skeete Tatum

6.7 Feb 24, 2020: 2020 Catalyst award winner Medtronic hires Chief Inclusion and Diversity Officer

6.8 Feb 24, 2020: 2020 Catalyst Award Winner Medtronic hires Chief Inclusion and Diversity Officer

6.9 Feb 19, 2020: Integra LifeSciences reports fourth quarter and full-year 2019 financial results and provides 2020 financial guidance

6.10 Feb 19, 2020: Duke University and Leica Microsystems establish Center of Excellence in Microscopy

6.11 Feb 18, 2020: Medtronic reports third quarter financial results 2020

6.12 Feb 12, 2020: ClearPoint Neuro reports 53% increase in 2019 revenue

6.13 Feb 06, 2020: Cardinal Health reports second quarter results for fiscal year 2020

6.14 Feb 05, 2020: Stryker expands Flower Mound regional headquarters

7 Appendix

For more information about this report visit

Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Editor Details

  • Company:
    • Businesswire
Last Updated: 15-Jan-2021